Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Ladenburg Thalmann Downgrades Itamar Medical to Neutral, Announces $33.85 Price Target

Author: Benzinga Newsdesk | September 15, 2021 07:38am
Ladenburg Thalmann analyst Jeffrey Cohen downgrades Itamar Medical (NASDAQ:ITMR) from Buy to Neutral and announces $33.85 price target.

Posted In: ITMR